Hope for a rabies eradication strategy in AfricaJanuary 22, 2009Most of the rabies virus circulating in dogs in western and central Africa comes from a common ancestor introduced to the continent around 200 years ago, probably by European colonialists. In the current issue of Journal of General Virology a team of scientists from Africa, USA and France report that within this common ancestry there are distinct subspecies at country level and that there is only limited movement of virus between localities. These factors mean that, if neighbouring countries collaborate, a progressive strategy to eliminate rabies from this area of sub-Saharan Africa is possible. Rabies causes over 24,000 deaths a year in Africa, mostly in poor rural communities and of children. Rabies prevention and treatment are costly and the necessary resources often scarce or inadequate. Controlling rabies in dogs, the main agents of rabies spread, is therefore an important part of any rabies eradication programme. The team analysed 182 samples of dog rabies virus from 27 African countries taken over a time period of 29 years. Their analyses showed that the samples were of two types, which they call "Africa 1" and "Africa 2" with different geographical distribution and history, indicating a clear distinction between rabies viruses circulating in North Africa and those circulating in West/Central Africa. It appeared that "Africa 2" was introduced into the eastern part of West/Central Africa - probably in Chad - around 200 years ago and from there spread over the whole region, moving westwards and southwards, over a 100-year period. This spread follows the pattern of French colonial expansion in Africa. Distinct subpopulations of the virus exist in the different African countries and there is very little evidence that there is much movement of the virus among localities. Dr Hervé Bourhy, from the Institut Pasteur in Paris who led the research said: "Some scientists have suggested that rabies outbreaks in Africa might be caused by "superspreader" dogs, transmitting the disease over large distances. Our findings show that this is extremely unlikely as there is strong geographical clustering of the dog rabies subspecies and the time-scale for diffusion of the virus is measured in decades. Similarly, people transporting dogs, some of them eventually becoming infectious or in incubation, over this vast region does not seem to have had much, if any, impact on the spread of disease". Chiraz Talbi, the researcher who carried out the analysis, added: "Rabies kills a patient, most often a child, every 20 minutes in Africa. By identifying the species of the virus that is the most prevalent and demonstrating how it spreads through the region, we have shown that, with collaboration, it should be possible for African countries to eliminate rabies by controlling dog rabies" Society for General Microbiology |
|||||||||||||||||||||
| Related Rabies Current Events and Rabies News Articles First human gets new antibody aimed at rabies virus MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus. New rabies vaccine may require only a single shot... not 6 A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center. Rabies deaths from dog bites could be eliminated Someone in the developing world - particularly in rural Africa - dies from a rabid dog bite every 10 minutes. CSHL researchers pinpoint structure-building role for 2 non-coding RNAs Most of the DNA in the nucleus of each of our cells is converted into RNA, but only a small fraction of these RNA molecules serve as coding templates for the synthesis of proteins. Evolution of new brain area enables complex movements A new area of the cerebral cortex has evolved to enable man and higher primates to pick up small objects and deftly use tools, according to neuroscientists at the University of Pittsburgh School of Medicine and Pittsburgh's Veterans Affairs Medical Center. Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. China sees spike in rabies cases A new Chinese study has reported a dramatic spike in rabies infections. The research, published today in the open access journal BMC Infectious Diseases, shows that in some provinces of China the number of human rabies cases has jumped dramatically since the new millennium. Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease. A simplified method of giving rabies vaccine A simplified economical method of giving rabies vaccine is just as effective as the expensive standard vaccine regimen at stimulating anti-rabies antibodies. More Rabies Current Events and Rabies News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||